These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 1359769)

  • 1. Molecular characterization of cloned variants of Coxiella burnetii isolated in China.
    Ning Z; Yu SR; Quan YG; Xue Z
    Acta Virol; 1992 Mar; 36(2):173-83. PubMed ID: 1359769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of proteins and lipopolysaccharides from Chinese isolates of Coxiella burnetii with monoclonal antibodies.
    Wen BH; Yu SR; Yu GQ; Li QJ; Zhang X
    Acta Virol; 1991 Nov; 35(6):538-44. PubMed ID: 1687637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coxiella burnetii phase I and II proteins studied by SDS-page.
    Lukácová M; Kazár J; Gajdosová E
    Acta Virol; 1994 Oct; 38(5):263-7. PubMed ID: 7726000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunological consequences of Coxiella burnetii phase variation.
    Quevedo Diaz MA; Lukácová M
    Acta Virol; 1998 Jun; 42(3):181-5. PubMed ID: 9842448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved method of isolation of Coxiella burnetii proteins.
    Lukácová M; Kazár J
    Acta Virol; 1996 Feb; 40(1):55-8. PubMed ID: 8886100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of protein and lipopolysaccharide patterns of several Coxiella burnetii strains in phase I.
    Novák M; Brezina R
    Acta Virol; 1989 Mar; 33(2):172-6. PubMed ID: 2569814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequencing and characterization of the cryptic plasmid QpRS from Coxiella burnetii.
    Lautenschläger S; Willems H; Jäger C; Baljer G
    Plasmid; 2000 Jul; 44(1):85-8. PubMed ID: 10873529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase variation of Coxiella burnetii strain Priscilla: influence of this phenomenon on biochemical features of its lipopolysaccharide.
    Ftácek P; Skultéty L; Toman R
    J Endotoxin Res; 2000; 6(5):369-76. PubMed ID: 11521057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physical mapping of the Coxiella burnetii genome.
    Frazier ME; Heinzen RA; Stiegler GL; Mallavia LP
    Acta Virol; 1991 Nov; 35(6):511-8. PubMed ID: 1687633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase variation of lipopolysaccharide of Coxiella burnetii, strain Priscilla during chick embryo yolk sac passaging.
    Lukácová M; Kazár J; Gajdosová E; Vavreková M
    FEMS Microbiol Lett; 1993 Nov; 113(3):285-9. PubMed ID: 8270193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotypic and genotypic heterogeneity of 8 new human Coxiella burnetti isolates.
    Stein A; Raoult D
    Acta Virol; 1992 Jan; 36(1):7-12. PubMed ID: 1350176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On the determination of "Kdo-like substance" in the lipopolysaccharide from Coxiella burnetii strain nine mile in phase II.
    Toman R; Skultéty L; Kazár J
    Acta Virol; 1993; 37(2-3):196-8. PubMed ID: 8105667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of the 3-deoxy-D-manno-2-octulosonic acid region in a lipopolysaccharide isolated from Coxiella burnetii strain Nine Mile in phase II.
    Toman R; Skultéty L
    Acta Virol; 1994 Aug; 38(4):241-3. PubMed ID: 7879717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of strain-specific plasmid sequences from Coxiella burnetii.
    Minnick MF; Small CL; Frazier ME; Mallavia LP
    Acta Virol; 1991 Nov; 35(6):497-502. PubMed ID: 1687630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonal antibody based differentiation of Coxiella burnetii isolates.
    Sekeyová Z; Thiele D; Krauss H; Karo M; Kazár J
    Acta Virol; 1996 Jun; 40(3):127-32. PubMed ID: 8891091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coxiella burnetii plasmid types QpDG and QpH1 are closely related and likely identical.
    Jäger C; Lautenschläger S; Willems H; Baljer G
    Vet Microbiol; 2002 Oct; 89(2-3):161-6. PubMed ID: 12243893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of various methods of lipopolysaccharide isolation from Coxiella burnetii strain Priscilla in the virulent phase I.
    Skultéty L; Toman R
    Acta Virol; 1994 Aug; 38(4):209-13. PubMed ID: 7879711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different antigenic properties of lipopolysaccharides isolated from Coxiella burnetii in phase I and pure phase II.
    Schramek S; Brezina R; Visacká E
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1983 Sep; 255(2-3):356-60. PubMed ID: 6417946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishment of a genotyping scheme for Coxiella burnetii.
    Svraka S; Toman R; Skultety L; Slaba K; Homan WL
    FEMS Microbiol Lett; 2006 Jan; 254(2):268-74. PubMed ID: 16445755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of the O-antigen biosynthesis regions of phase II isolates of Coxiella burnetii.
    Denison AM; Massung RF; Thompson HA
    FEMS Microbiol Lett; 2007 Feb; 267(1):102-7. PubMed ID: 17156123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.